Disseminated Kaposi′s sarcoma with the involvement of penis in the setting of Hiv infection

Farshidpour, Maham; Marjani, Majid; Baghaei, Parvaneh; Tabarsi, Payam; Masjedi, Heidar; Kani, Zahra Farzaneh Asadi; Nadji, Seyed Alireza; Mansouri, Davood

doi:10.4103/0019-5154.147852

Cited by 5 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…AIDS-related KS responds well to HAART therapy, and systemic chemotherapeutic drugs are indicated in nonresponsive patients or in patients with systemic involvement. [ 8 9 ] Liposomal anthracyclines (doxorubicin and daunorubicin) are the United States Food and Drug Administration approved first-line agent for treatment of KS. Due to its side-effect profile, paclitaxel is preferred as a second-line agent.…”

Section: Discussionmentioning

confidence: 99%

Disseminated kaposi's sarcoma in an HIV-positive patient: A rare entity in an Indian patient

et al. 2016

View full text Add to dashboard Cite

AIDS-associated disseminated Kaposi sarcoma (KS) is a rare entity, especially in India due to the low prevalence of human herpes virus-8 infections in Indian population. Due to its rapid and progressive nature, early diagnosis and institution of highly active antiretroviral therapy is crucial in AIDS-associated KS, with a view to achieving favorable prognosis. We report a case of disseminated KS in an HIV-1 positive patient, who presented with two months history of multiple violaceous patches and plaques over the trunk, bilateral upper limbs, lower limbs, and hard palate. The patient died of recurrent massive pleural effusion before starting antiretroviral therapy. This case is being reported due to the paucity of KS in the Indian literature, especially the disseminated type and to highlight its rapidly progressive course which can be fatal.

show abstract

Section: Discussionmentioning

confidence: 99%